Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.19.1
CONDENSED BALANCE SHEETS - USD ($)
Feb. 28, 2019
Aug. 31, 2018
Current assets    
Cash and cash equivalents $ 107,936 $ 199,674
Prepaid expenses 41,082 0
Inventory 0 9,402
Total current assets 149,018 209,076
Investment in TruPet 2,200,000 0
Total Assets 2,349,018 209,076
Current liabilities    
Accounts payable and accrued liabilities 104,912 106,445
Accrued interest, related party 1,657 0
Dividends payable 98,595 20,280
Derivative liability 2,432,459 2,317,412
Accrued officer salary 108,000 140,000
Convertible notes, net of unamortized debt discounts of $0 and $752,990, respectively 0 274,214
Total current liabilities 2,745,623 2,858,351
Commitments and contingencies
Stockholders’ deficit    
Common stock, $0.001 par value, 580,000,000 shares authorized 2,699,502 and 3,064,763 shares (post-reverse split) issued and outstanding as of February 28, 2019 and August 31, 2018, respectively 2,700 3,065
Additional paid-in capital 5,318,132 3,406,146
Accumulated deficit (5,720,130) (6,059,291)
Total stockholders' equity (deficit) (396,605) (2,649,275)
Total liabilities and stockholders' equity (deficit) 2,349,018 209,076
Series A Preferred Stock [Member]    
Stockholders’ deficit    
Preferred stock 0 1
Series B Preferred Stock [Member]    
Stockholders’ deficit    
Preferred stock 0 804
Series E Preferred Stock [Member]    
Stockholders’ deficit    
Preferred stock $ 2,693 $ 0